Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

PURPOSE: The purpose of this study was to compare ramosetron (RAM), aprepitant (APR), and dexamethasone (DEX) [RAD] with palonosetron (PAL), APR, and DEX [PAD] in controlling highly-emetogenic chemotherapy (HEC)–induced nausea and vomiting. MATERIALS AND METHODS: Patients were randomly assigned (1:1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Kang, Jin Hyoung, Kwon, Jung Hye, Lee, Yun-Gyoo, Park, Keon Uk, An, Ho Jung, Sohn, Joohyuk, Seol, Young Mi, Lee, Hyunwoo, Yun, Hwan-Jung, Ahn, Jin Seok, Yang, Ji Hyun, Song, Hunho, Koo, Dong-Hoe, Kim, Jin Young, Kim, Gun Min, Kim, Hwa Jung
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373869/
https://ncbi.nlm.nih.gov/pubmed/32192275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.713
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados